News from bayer healthcare pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 11, 2015, 11:18 ET
Bayer's Breathless Moments Contest Winning Photo taken by Patricia Middings of Chester, N.J.

Chester, N.J. Woman Wins Bayer's Breathless Moments Contest

 Bayer is pleased to announce the winner of Breathless Moments, a photo contest designed to raise awareness about chronic...

Feb 23, 2015, 17:01 ET
Bayer logo

Bayer Presents Latest Oncology Research at ASCO GU 2015

 Bayer HealthCare Pharmaceuticals Inc. announced today that new data on Xofigo® (radium Ra 223 dichloride) injection will be...

Feb 23, 2015, 09:00 ET
Bayer logo

Bayer Healthcare Expands Patient Assistance Program To Include An Additional Intrauterine Device At No Cost To Women Who Qualify

Bayer HealthCare Pharmaceuticals Inc. today announced the expansion of its patient assistance program for intrauterine devices (IUD). The ARCH...

Nov 03, 2014, 09:37 ET
Bayer logo.

Bayer HealthCare & KARL STORZ Enter Collaboration Agreement to Provide Gynecologists Hysteroscopy Solutions Supporting the Procedure for Essure® Permanent Birth Control

Bayer HealthCare Pharmaceuticals, Inc. today announced that it has entered into a collaborative agreement with KARL STORZ Endoscopy-America, Inc....

Sep 24, 2014, 02:30 ET

ESMO 2014 to Feature New Oncology Data from Across Bayer Franchise

 Bayer HealthCare Pharmaceuticals Inc. announced today that data from its oncology portfolio, including Stivarga® (regorafenib) tablets,...

Sep 16, 2014, 02:30 ET

Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer

 Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial...

Aug 13, 2014, 08:30 ET

Over 1,000 Medical Sites in the United States Now Licensed to Administer Xofigo® (radium Ra 223 dichloride) Injection

Bayer HealthCare Inc. today announced that, approximately one year following the national launch, over 1,000 sites in the United States have...

Jul 25, 2014, 02:30 ET

Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer

 Bayer HealthCare and Onyx Pharmaceuticals Inc., an Amgen subsidiary (NASDAQ: AMGN), today announced that an investigational Phase 3 trial of...

Jun 02, 2014, 09:00 ET
New Bayer Inserter for Mirena and Skyla (PRNewsFoto/Bayer HealthCare Pharmaceuticals)

Bayer HealthCare Pharmaceuticals Introduces New Bayer Inserter For Mirena® (Levonorgestrel-Releasing Intrauterine System) 52 Mg

 Bayer HealthCare Pharmaceuticals Inc. today announced Food and Drug Administration (FDA) approval of a new inserter for Mirena®. Bayer...

Apr 23, 2014, 19:02 ET
Bayer HealthCare logo (PRNewsFoto/Bayer HealthCare Pharmaceuticals)

Phase 3 DECISION Trial of NEXAVAR (sorafenib) in Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory to Radioactive Iodine Published in The Lancet

 Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that The Lancet...

Mar 11, 2014, 03:30 ET
Bayer HealthCare Pharmaceuticals Inc.  (PRNewsFoto/Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary)

Bayer and Onyx Report Phase 3 Study Results of NEXAVAR® (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation

 Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial...

Mar 03, 2014, 08:00 ET

Advocacy Organization Fight Colorectal Cancer and Bayer Kick-Start Colorectal Cancer Awareness Month at National Historic Landmark

To raise awareness about colorectal cancer—the nation's second leading cause of cancer-related deaths—Fight Colorectal...

Feb 20, 2014, 02:30 ET

Bayer Initiates Phase III Trial of Stivarga® (regorafenib) Tablets in Patients with Colorectal Cancer after Resection of Liver Metastases

 Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga®...

Feb 18, 2014, 02:15 ET

Bayer's Long-Acting Recombinant Factor VIII Demonstrated Prophylaxis with Less Frequent Infusions in Hemophilia A in Phase III Trial

Bayer HealthCare today announced positive results from the PROTECT VIII trial evaluating the company's investigational...

Nov 22, 2013, 17:30 ET
Nov 20, 2013, 11:14 ET

Bayer's Third Annual Virtual Walk for Hemophilia Raises Funds, Brings Together the Hemophilia Community

 Bayer HealthCare and the National Hemophilia Foundation (NHF) today announced the successful conclusion of the third annual...

Oct 28, 2013, 09:51 ET

Bayer to Present Data Investigating Recently Approved Adempas® (riociguat) Tablets

 Bayer HealthCare today announced preliminary results from two ongoing, open-label, long-term extension studies investigating its recently...

Oct 08, 2013, 18:54 ET

FDA Approves Bayer's New Class of Drug Adempas® (riociguat) tablets to Treat Adults with PAH and Persistent, Recurrent or Inoperable CTEPH

Bayer HealthCare announced today that the United States Food and Drug Administration (FDA) has approved Adempas® (riociguat) tablets for: (i)...

Sep 25, 2013, 08:30 ET

Bayer's Investigational Drug Riociguat Granted FDA Orphan Drug Designation for Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

WHIPPANY, N.J., Sept. 25, 2013 /PRNewswire/ -- Bayer HealthCare today announced that the U.S. Food and Drug Administration's (FDA)...